Your browser doesn't support javascript.
loading
Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypes.
Hyeon, Do Young; Nam, Dowoon; Han, Youngmin; Kim, Duk Ki; Kim, Gibeom; Kim, Daeun; Bae, Jingi; Back, Seunghoon; Mun, Dong-Gi; Madar, Inamul Hasan; Lee, Hangyeore; Kim, Su-Jin; Kim, Hokeun; Hyun, Sangyeop; Kim, Chang Rok; Choi, Seon Ah; Kim, Yong Ryoul; Jeong, Juhee; Jeon, Suwan; Choo, Yeon Woong; Lee, Kyung Bun; Kwon, Wooil; Choi, Seunghyuk; Goo, Taewan; Park, Taesung; Suh, Young-Ah; Kim, Hongbeom; Ku, Ja-Lok; Kim, Min-Sik; Paek, Eunok; Park, Daechan; Jung, Keehoon; Baek, Sung Hee; Jang, Jin-Young; Hwang, Daehee; Lee, Sang-Won.
Afiliación
  • Hyeon DY; School of Biological Sciences, Seoul National University, Seoul, Republic of Korea.
  • Nam D; Department of Chemistry and Center for Proteogenome Research, Korea University, Seoul, Republic of Korea.
  • Han Y; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Kim DK; Department of Anatomy and Cell Biology and Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Kim G; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Seoul, Republic of Korea.
  • Kim D; School of Biological Sciences, Seoul National University, Seoul, Republic of Korea.
  • Bae J; Creative Research Initiatives Center for Epigenetic Code and Diseases, Seoul National University, Seoul, Republic of Korea.
  • Back S; Department of Biological Sciences, College of Natural Sciences and Department of Molecular Science and Technology, Ajou University, Suwon, Republic of Korea.
  • Mun DG; Department of Chemistry and Center for Proteogenome Research, Korea University, Seoul, Republic of Korea.
  • Madar IH; Department of Chemistry and Center for Proteogenome Research, Korea University, Seoul, Republic of Korea.
  • Lee H; Department of Chemistry and Center for Proteogenome Research, Korea University, Seoul, Republic of Korea.
  • Kim SJ; Department of Chemistry and Center for Proteogenome Research, Korea University, Seoul, Republic of Korea.
  • Kim H; Department of Chemistry and Center for Proteogenome Research, Korea University, Seoul, Republic of Korea.
  • Hyun S; Department of Chemistry and Center for Proteogenome Research, Korea University, Seoul, Republic of Korea.
  • Kim CR; Department of Chemistry and Center for Proteogenome Research, Korea University, Seoul, Republic of Korea.
  • Choi SA; Department of Biological Sciences, College of Natural Sciences and Department of Molecular Science and Technology, Ajou University, Suwon, Republic of Korea.
  • Kim YR; School of Biological Sciences, Seoul National University, Seoul, Republic of Korea.
  • Jeong J; Creative Research Initiatives Center for Epigenetic Code and Diseases, Seoul National University, Seoul, Republic of Korea.
  • Jeon S; School of Biological Sciences, Seoul National University, Seoul, Republic of Korea.
  • Choo YW; Creative Research Initiatives Center for Epigenetic Code and Diseases, Seoul National University, Seoul, Republic of Korea.
  • Lee KB; School of Biological Sciences, Seoul National University, Seoul, Republic of Korea.
  • Kwon W; Creative Research Initiatives Center for Epigenetic Code and Diseases, Seoul National University, Seoul, Republic of Korea.
  • Choi S; Department of Anatomy and Cell Biology and Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Goo T; Department of Anatomy and Cell Biology and Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Park T; Department of Anatomy and Cell Biology and Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Suh YA; Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
  • Kim H; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Ku JL; Department of Computer Science, Hanyang University, Seoul, Republic of Korea.
  • Kim MS; Interdisciplinary Program in Bioinformatics, Seoul National University, Seoul, Republic of Korea.
  • Paek E; Department of Statistics, Seoul National University, Seoul, Republic of Korea.
  • Park D; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Jung K; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Baek SH; Korean Cell Line Bank, Laboratory of Cell Biology, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Jang JY; Department of New Biology, Daegu Gyeongbuk Institute of Science and Technology, Daegu, Republic of Korea.
  • Hwang D; Department of Computer Science, Hanyang University, Seoul, Republic of Korea.
  • Lee SW; Department of Biological Sciences, College of Natural Sciences and Department of Molecular Science and Technology, Ajou University, Suwon, Republic of Korea. dpark@ajou.ac.kr.
Nat Cancer ; 4(2): 290-307, 2023 02.
Article en En | MEDLINE | ID: mdl-36550235
ABSTRACT
We report a proteogenomic analysis of pancreatic ductal adenocarcinoma (PDAC). Mutation-phosphorylation correlations identified signaling pathways associated with somatic mutations in significantly mutated genes. Messenger RNA-protein abundance correlations revealed potential prognostic biomarkers correlated with patient survival. Integrated clustering of mRNA, protein and phosphorylation data identified six PDAC subtypes. Cellular pathways represented by mRNA and protein signatures, defining the subtypes and compositions of cell types in the subtypes, characterized them as classical progenitor (TS1), squamous (TS2-4), immunogenic progenitor (IS1) and exocrine-like (IS2) subtypes. Compared with the mRNA data, protein and phosphorylation data further classified the squamous subtypes into activated stroma-enriched (TS2), invasive (TS3) and invasive-proliferative (TS4) squamous subtypes. Orthotopic mouse PDAC models revealed a higher number of pro-tumorigenic immune cells in TS4, inhibiting T cell proliferation. Our proteogenomic analysis provides significantly mutated genes/biomarkers, cellular pathways and cell types as potential therapeutic targets to improve stratification of patients with PDAC.
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma de Células Escamosas / Carcinoma Ductal Pancreático / Proteogenómica Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Nat Cancer Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma de Células Escamosas / Carcinoma Ductal Pancreático / Proteogenómica Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Nat Cancer Año: 2023 Tipo del documento: Article